Masayuki Hojo

2.4k total citations
103 papers, 840 citations indexed

About

Masayuki Hojo is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Physiology. According to data from OpenAlex, Masayuki Hojo has authored 103 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 31 papers in Infectious Diseases and 30 papers in Physiology. Recurrent topics in Masayuki Hojo's work include Asthma and respiratory diseases (26 papers), COVID-19 Clinical Research Studies (24 papers) and SARS-CoV-2 and COVID-19 Research (19 papers). Masayuki Hojo is often cited by papers focused on Asthma and respiratory diseases (26 papers), COVID-19 Clinical Research Studies (24 papers) and SARS-CoV-2 and COVID-19 Research (19 papers). Masayuki Hojo collaborates with scholars based in Japan, United States and Canada. Masayuki Hojo's co-authors include Haruhito Sugiyama, Motoyasu Iikura, James G. Martin, Shinyu Izumi, Nobuyuki Kobayashi, Koichiro Kudo, Satoru Ishii, Norio Ohmagari, Satoshi Hirano and Karim Maghni and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Masayuki Hojo

96 papers receiving 819 citations

Peers

Masayuki Hojo
Jens Schreiber Germany
Jennifer D. Possick United States
Emily Bowman United States
Terence Ho Canada
Ina Callebaut Belgium
Hanxiang Nie China
Oliviero Rossi Italy
C. Fournier France
Catherine M. Biggs Canada
Katsunori Masaki Japan
Jens Schreiber Germany
Masayuki Hojo
Citations per year, relative to Masayuki Hojo Masayuki Hojo (= 1×) peers Jens Schreiber

Countries citing papers authored by Masayuki Hojo

Since Specialization
Citations

This map shows the geographic impact of Masayuki Hojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Hojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Hojo more than expected).

Fields of papers citing papers by Masayuki Hojo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Hojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Hojo. The network helps show where Masayuki Hojo may publish in the future.

Co-authorship network of co-authors of Masayuki Hojo

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Hojo. A scholar is included among the top collaborators of Masayuki Hojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Hojo. Masayuki Hojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Itoh, Naoya, Masahiro Ishikane, Noriko Iwamoto, et al.. (2025). Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients. Journal of Infection and Chemotherapy. 31(4). 102631–102631. 2 indexed citations
2.
Furusawa, Yuri, Maki Kiso, Ryuta Uraki, et al.. (2025). Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures. Journal of Virology. 99(3). e0221724–e0221724.
3.
Masaki, Katsunori, Maho Suzukawa, Norihiro Harada, et al.. (2024). Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial. Allergology International. 74(2). 274–282. 3 indexed citations
4.
Suzuki, Manabu, Masakazu Sugino, Eriko Morino, et al.. (2024). Preliminary investigation of the significance of cavitary lesions in recurrent hemoptysis following bronchial artery embolization for nontuberculous mycobacterial pulmonary disease. Respiratory Investigation. 62(6). 1227–1232. 1 indexed citations
5.
6.
Ishii, Satoru, et al.. (2023). Diagnosis of diffuse panbronchiolitis by transbronchial lung cryobiopsy. Heliyon. 9(4). e15127–e15127. 1 indexed citations
7.
Hashimoto, Masao, et al.. (2023). A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor. Thoracic Cancer. 14(19). 1894–1898. 2 indexed citations
8.
Bouchi, Ryotaro, Noriko Ihana‐Sugiyama, Mitsuru Ohsugi, et al.. (2023). A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma. Journal of Diabetes Investigation. 15(3). 388–390. 3 indexed citations
9.
Suzuki, Manabu, Akihiro Matsunaga, Tohru Miyoshi‐Akiyama, et al.. (2023). Inhaled ciclesonide does not affect production of antibodies or elimination of virus in patients with COVID-19: Subanalysis of a multicenter, open-label randomized trial. Drug Discoveries & Therapeutics. 17(5). 304–311. 1 indexed citations
10.
Hojo, Masayuki, et al.. (2023). Treatment options for patients with severe COVID-19. Global Health & Medicine. 5(2). 99–105. 2 indexed citations
11.
Suzuki, Manabu, Keita Sakamoto, Kentaro Tamura, et al.. (2023). Clinical usefulness of end‐tidal CO2 measured using a portable capnometer in patients with respiratory disease. The Clinical Respiratory Journal. 17(2). 96–104. 2 indexed citations
12.
Suzuki, Manabu, Masao Hashimoto, Satoru Ishii, et al.. (2022). Endobronchial hamartoma resected via bronchoscopy using high-frequency electrosurgical snare–Preoperative strategies using virtual bronchoscopy. SHILAP Revista de lepidopterología. 17(11). 4232–4238.
13.
Tsuzuki, Shinya, Sho Saito, Shin-ichiro Hattori, et al.. (2022). Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan. Journal of Infection and Chemotherapy. 28(9). 1340–1343. 1 indexed citations
14.
Izumi, Shinyu, Masao Hashimoto, Satoru Ishii, et al.. (2022). COVID‐19 mRNA vaccine‐related interstitial lung disease: Two case reports and literature review. SHILAP Revista de lepidopterología. 10(4). e0938–e0938. 11 indexed citations
15.
Hashimoto, Masao, Go Naka, Motoyasu Iikura, et al.. (2022). A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma. Thoracic Cancer. 13(14). 2075–2077. 2 indexed citations
16.
Makita, Kosuke, Yu Mikami, Hirotaka Matsuzaki, et al.. (2018). Mechanism of Periostin Production in Human Bronchial Smooth Muscle Cells. International Archives of Allergy and Immunology. 175(1-2). 26–35. 11 indexed citations
17.
Goto, Yasushi, Masayuki Hojo, Yuichiro Takeda, Nobuyuki Kobayashi, & Koichiro Kudo. (2009). Gefitinib-induced interstitial lung disease-addition of intravenous cyclophosphamide to corticosteroids is a valuable treatment option: A case report. Medical Oncology. 27(3). 753–755. 3 indexed citations
18.
Hojo, Masayuki, et al.. (1998). CD4 + T Cells Can Induce Airway Hyperresponsiveness to Allergen Challenge in the Brown Norway Rat. American Journal of Respiratory and Critical Care Medicine. 158(6). 1863–1870. 31 indexed citations
19.
Hojo, Masayuki, Karim Maghni, Thomas B. Issekutz, & James G. Martin. (1998). Involvement of α -4 Integrins in Allergic Airway Responses and Mast Cell Degranulation In Vivo. American Journal of Respiratory and Critical Care Medicine. 158(4). 1127–1133. 30 indexed citations
20.
Watanabe, Azuma, T. Kotsimbos, Masayuki Hojo, et al.. (1997). Adoptively Transferred Late Allergic Airway Responses are Associated with Th2-Type Cytokines in the Rat. American Journal of Respiratory Cell and Molecular Biology. 16(1). 69–74. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Schreiber Breakdown of academic impact, for papers by Jennifer D. Possick Breakdown of academic impact, for papers by Emily Bowman Breakdown of academic impact, for papers by Terence Ho Breakdown of academic impact, for papers by Ina Callebaut Breakdown of academic impact, for papers by Hanxiang Nie Breakdown of academic impact, for papers by Oliviero Rossi Breakdown of academic impact, for papers by C. Fournier Breakdown of academic impact, for papers by Catherine M. Biggs Breakdown of academic impact, for papers by Katsunori Masaki
Rankless by CCL
2026